Michelle L. Basil is the Executive Vice President and General Counsel at Haemonetics Corporation, a global leader in blood and plasma supplies and services. With an impressive legal background, Basil has been instrumental in guiding Haemonetics through complex legal and regulatory landscapes. Prior to joining Haemonetics, she held significant roles at major corporations, including serving as Senior Vice President, General Counsel, and Corporate Secretary at Catalent Pharma Solutions. Her experience spans various industries, showcasing her versatility and deep understanding of corporate law. At Haemonetics, Basil's role encompasses overseeing all legal matters, including corporate governance, compliance, and intellectual property. Her strategic vision and leadership have been pivotal in navigating the company through mergers and acquisitions, ensuring that Haemonetics remains at the forefront of innovation and market expansion. Basil's contributions have not only strengthened the company's legal framework but also supported its mission to enhance patient care through advanced medical technologies. Basil's achievements extend beyond her corporate responsibilities. She is recognized for her commitment to fostering a culture of integrity and ethical practices within the workplace. Her leadership style emphasizes collaboration and transparency, which has earned her respect among peers and subordinates alike. Under her guidance, Haemonetics continues to uphold its reputation as a trusted partner in the healthcare industry, dedicated to improving lives worldwide.